JP2023526050A5 - - Google Patents

Info

Publication number
JP2023526050A5
JP2023526050A5 JP2022568810A JP2022568810A JP2023526050A5 JP 2023526050 A5 JP2023526050 A5 JP 2023526050A5 JP 2022568810 A JP2022568810 A JP 2022568810A JP 2022568810 A JP2022568810 A JP 2022568810A JP 2023526050 A5 JP2023526050 A5 JP 2023526050A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
compound
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022568810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526050A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/032249 external-priority patent/WO2021231726A1/en
Publication of JP2023526050A publication Critical patent/JP2023526050A/ja
Publication of JP2023526050A5 publication Critical patent/JP2023526050A5/ja
Pending legal-status Critical Current

Links

JP2022568810A 2020-05-14 2021-05-13 Enpp1モジュレーターおよびその使用 Pending JP2023526050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063024937P 2020-05-14 2020-05-14
US63/024,937 2020-05-14
PCT/US2021/032249 WO2021231726A1 (en) 2020-05-14 2021-05-13 Enpp1 modulators and uses thereof

Publications (2)

Publication Number Publication Date
JP2023526050A JP2023526050A (ja) 2023-06-20
JP2023526050A5 true JP2023526050A5 (cg-RX-API-DMAC10.html) 2024-05-20

Family

ID=76250495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568810A Pending JP2023526050A (ja) 2020-05-14 2021-05-13 Enpp1モジュレーターおよびその使用

Country Status (13)

Country Link
US (1) US20230183188A1 (cg-RX-API-DMAC10.html)
EP (1) EP4149927A1 (cg-RX-API-DMAC10.html)
JP (1) JP2023526050A (cg-RX-API-DMAC10.html)
KR (1) KR20230012535A (cg-RX-API-DMAC10.html)
CN (1) CN116348451A (cg-RX-API-DMAC10.html)
AR (1) AR122090A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021273001A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022023112A2 (cg-RX-API-DMAC10.html)
CA (1) CA3178372A1 (cg-RX-API-DMAC10.html)
IL (1) IL298169A (cg-RX-API-DMAC10.html)
MX (1) MX2022014126A (cg-RX-API-DMAC10.html)
TW (1) TW202208336A (cg-RX-API-DMAC10.html)
WO (1) WO2021231726A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021225969A1 (en) * 2020-05-04 2021-11-11 Volastra Therapeutics, Inc. Imino sulfanone inhibitors of enpp1
WO2022091048A1 (en) 2020-10-30 2022-05-05 Integral Biosciences Private Limited Ectonucleotide pyrophosphatase-phosphodiesterase-1 (enpp1) inhibitors and uses thereof
WO2023086638A1 (en) * 2021-11-15 2023-05-19 Vir Biotechnology, Inc. Enpp1 modulators and uses thereof
US20260049084A1 (en) * 2022-05-13 2026-02-19 Gossamer Bio Services, Inc. Enpp1 modulators and products and uses thereof
US12397517B2 (en) 2023-10-23 2025-08-26 Unik World Industrial Co., Ltd. Vehicle-mounted air compressor
IL328533A (en) * 2023-11-29 2026-07-01 Riboscience Llc Bicyclic heteroaryl derivatives of 7-AZA as inhibitors of acetylnucleotide pyrophosphatase phosphodiesterase 1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100477070B1 (ko) 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US6334997B1 (en) 1994-03-25 2002-01-01 Isotechnika, Inc. Method of using deuterated calcium channel blockers
WO2017066964A1 (en) * 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
WO2018119328A1 (en) * 2016-12-22 2018-06-28 Mavupharma, Inc. Phosphodiesterase inhibitors and methods of microbial treatment
AU2018325445A1 (en) * 2017-08-31 2020-03-19 Abbvie Inc. Ectonucleotide pyrophosphatase-phosphodiesterase 1 (ENPP-1) inhibitors and uses thereof
WO2019177971A1 (en) * 2018-03-12 2019-09-19 Mavupharma, Inc. Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof
WO2021061803A1 (en) * 2019-09-23 2021-04-01 Nanjing Zhengxiang Pharmaceuticals Co., Ltd. Phosphodiesterase inhibitors and use
WO2021225969A1 (en) * 2020-05-04 2021-11-11 Volastra Therapeutics, Inc. Imino sulfanone inhibitors of enpp1

Similar Documents

Publication Publication Date Title
JP2023553835A5 (cg-RX-API-DMAC10.html)
JP2022516469A5 (cg-RX-API-DMAC10.html)
JP2022507724A5 (cg-RX-API-DMAC10.html)
JP2021532109A5 (cg-RX-API-DMAC10.html)
JP2022545633A5 (cg-RX-API-DMAC10.html)
JP2023500328A5 (cg-RX-API-DMAC10.html)
JP2012526728A5 (cg-RX-API-DMAC10.html)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
JP2023515617A5 (cg-RX-API-DMAC10.html)
ATE377007T1 (de) Thiazol- und oxazolderivate, die sich für die behandlung von herzkreislauferkrankungen und ähnlichen erkrankungen eignen
AR084976A1 (es) Compuestos de bifenileno sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales
HRP20151370T1 (hr) Derivati benzotiazola kao sredstva protiv raka
JP2021531311A5 (cg-RX-API-DMAC10.html)
JP2021534108A5 (cg-RX-API-DMAC10.html)
JP2021500394A5 (cg-RX-API-DMAC10.html)
JP2013504593A5 (cg-RX-API-DMAC10.html)
JP2015509535A5 (cg-RX-API-DMAC10.html)
JP2023533203A5 (cg-RX-API-DMAC10.html)
RU2017110211A (ru) ИНГИБИТОРЫ α-АМИНО-β-КАРБОКСИМУКОНАТ-ε-СЕМИАЛЬДЕГИД-ДЕКАРБОКСИЛАЗЫ
JP2019510794A5 (cg-RX-API-DMAC10.html)
JP2022529518A5 (cg-RX-API-DMAC10.html)
RU2008107733A (ru) Ингибиторы gsk-3
JP2014514290A5 (cg-RX-API-DMAC10.html)
JP2022508642A5 (cg-RX-API-DMAC10.html)
JP2008517923A5 (cg-RX-API-DMAC10.html)